Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Carducci

Showing results (1-10 of 322) with videos related to

Pageof 33
Sort By:
Reviews in Urology|September 21, 2006
Prostate cancer update: advanced diseaseMichael A Carducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2023
Flashback Foreword: Pazopanib in Renal Cell Carcinoma and Overall Survival With Sunitinib Versus Interferon-α in Metastatic Renal Cell CarcinomaMichael A Carducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
What is more exciting? The activity of docetaxel in early prostate cancer or the successful collaboration between urologists and medical oncologists to complete a study in early prostate cancer?Michael A Carducci
The Johns Hopkins Medical Letter Health After 50|July 6, 2004
The healing power of hopeMichael A Carducci
Expert Opinion on Investigational Drugs|February 25, 2009
HIF-1alpha inhibition as a novel mechanism of cardiac glycosides in cancer therapeuticsJianqing Lin, Michael A Carducci
Seminars in Oncology|April 9, 2005
Palliative chemotherapy: historical perspective, applications, and controversiesIlene Browner, Michael A Carducci
Expert Opinion on Pharmacotherapy|June 5, 2003
Pharmacotherapy of hormone refractory prostate cancer: new developments and challengesEli Rosenbaum, Michael A Carducci
Idrugs : the Investigational Drugs Journal|February 8, 2005
Focus on deacetylation for therapeutic benefitShabana Shabbeer, Michael A Carducci
Nature Reviews. Urology|August 7, 2009
Intermittent androgen deprivation--questions remainDaniel Keizman, Michael A Carducci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Targeting bone metastasis in prostate cancer with endothelin receptor antagonistsMichael A Carducci, Antonio Jimeno
Pageof 33

Showing results (1-10 of 322) with videos related to

Sort By:
Pageof 33
Reviews in Urology|September 21, 2006
Prostate cancer update: advanced diseaseMichael A Carducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2023
Flashback Foreword: Pazopanib in Renal Cell Carcinoma and Overall Survival With Sunitinib Versus Interferon-α in Metastatic Renal Cell CarcinomaMichael A Carducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
What is more exciting? The activity of docetaxel in early prostate cancer or the successful collaboration between urologists and medical oncologists to complete a study in early prostate cancer?Michael A Carducci
The Johns Hopkins Medical Letter Health After 50|July 6, 2004
The healing power of hopeMichael A Carducci
Expert Opinion on Investigational Drugs|February 25, 2009
HIF-1alpha inhibition as a novel mechanism of cardiac glycosides in cancer therapeuticsJianqing Lin, Michael A Carducci
Seminars in Oncology|April 9, 2005
Palliative chemotherapy: historical perspective, applications, and controversiesIlene Browner, Michael A Carducci
Expert Opinion on Pharmacotherapy|June 5, 2003
Pharmacotherapy of hormone refractory prostate cancer: new developments and challengesEli Rosenbaum, Michael A Carducci
Idrugs : the Investigational Drugs Journal|February 8, 2005
Focus on deacetylation for therapeutic benefitShabana Shabbeer, Michael A Carducci
Nature Reviews. Urology|August 7, 2009
Intermittent androgen deprivation--questions remainDaniel Keizman, Michael A Carducci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Targeting bone metastasis in prostate cancer with endothelin receptor antagonistsMichael A Carducci, Antonio Jimeno
Pageof 33